202 related articles for article (PubMed ID: 16303162)
1. Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression.
DeMeritt IB; Podduturi JP; Tilley AM; Nogalski MT; Yurochko AD
Virology; 2006 Mar; 346(1):15-31. PubMed ID: 16303162
[TBL] [Abstract][Full Text] [Related]
2. Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.
DeMeritt IB; Milford LE; Yurochko AD
J Virol; 2004 May; 78(9):4498-507. PubMed ID: 15078930
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
[TBL] [Abstract][Full Text] [Related]
4. Activation of the virus-induced IKK/NF-kappaB signalling axis is critical for the replication of human cytomegalovirus in quiescent cells.
Caposio P; Luganini A; Hahn G; Landolfo S; Gribaudo G
Cell Microbiol; 2007 Aug; 9(8):2040-54. PubMed ID: 17419715
[TBL] [Abstract][Full Text] [Related]
5. Bcl-3-regulated transcription from major immediate-early promoter of human cytomegalovirus in monocyte-derived macrophages.
Khan KA; Coaquette A; Davrinche C; Herbein G
J Immunol; 2009 Jun; 182(12):7784-94. PubMed ID: 19494302
[TBL] [Abstract][Full Text] [Related]
6. Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells.
Caposio P; Musso T; Luganini A; Inoue H; Gariglio M; Landolfo S; Gribaudo G
Antiviral Res; 2007 Mar; 73(3):175-84. PubMed ID: 17070604
[TBL] [Abstract][Full Text] [Related]
7. The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha.
Nogalski MT; Podduturi JP; DeMeritt IB; Milford LE; Yurochko AD
J Virol; 2007 May; 81(10):5305-14. PubMed ID: 17344282
[TBL] [Abstract][Full Text] [Related]
8. The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells.
Caposio P; Luganini A; Bronzini M; Landolfo S; Gribaudo G
J Virol; 2010 May; 84(9):4481-93. PubMed ID: 20147408
[TBL] [Abstract][Full Text] [Related]
9. Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.
Kitagawa R; Takahashi Y; Takahashi M; Imazu H; Yasuda M; Sadanari H; Tanaka J
Virology; 2009 Jan; 383(2):195-206. PubMed ID: 19027925
[TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling.
Johnson RA; Wang X; Ma XL; Huong SM; Huang ES
J Virol; 2001 Jul; 75(13):6022-32. PubMed ID: 11390604
[TBL] [Abstract][Full Text] [Related]
11. The human cytomegalovirus UL26 protein antagonizes NF-κB activation.
Mathers C; Schafer X; Martínez-Sobrido L; Munger J
J Virol; 2014 Dec; 88(24):14289-300. PubMed ID: 25275128
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB activation can mediate inhibition of human cytomegalovirus replication.
Eickhoff JE; Cotten M
J Gen Virol; 2005 Feb; 86(Pt 2):285-295. PubMed ID: 15659747
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression.
Yurochko AD; Huang ES
J Immunol; 1999 Apr; 162(8):4806-16. PubMed ID: 10202024
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection in mesenchymal stem cells and their activation could be enhanced by nuclear factor-κB inhibitor pyrrolidinedithiocarbamate in vitro.
Wei G; Lin M; Cai Z; Huang H
Transplant Proc; 2011 Jun; 43(5):1944-9. PubMed ID: 21693305
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?
Prösch S; Wuttke R; Krüger DH; Volk HD
Biol Chem; 2002 Oct; 383(10):1601-9. PubMed ID: 12452437
[TBL] [Abstract][Full Text] [Related]
16. The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer.
Boomker JM; The TH; de Leij LF; Harmsen MC
Virus Res; 2006 Jun; 118(1-2):196-200. PubMed ID: 16448715
[TBL] [Abstract][Full Text] [Related]
17. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection.
Ahn JH; Hayward GS
Virology; 2000 Aug; 274(1):39-55. PubMed ID: 10936087
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.
Gustems M; Borst E; Benedict CA; Pérez C; Messerle M; Ghazal P; Angulo A
J Virol; 2006 Oct; 80(19):9899-904. PubMed ID: 16973595
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitor MG132 blocks viral DNA replication and assembly of human cytomegalovirus.
Kaspari M; Tavalai N; Stamminger T; Zimmermann A; Schilf R; Bogner E
FEBS Lett; 2008 Mar; 582(5):666-72. PubMed ID: 18242185
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
